Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015-2020.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
28 07 2022
Historique:
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 2 8 2022
Statut: epublish

Résumé

We verified subnational (state/union territory (UT)/district) claims of achievements in reducing tuberculosis (TB) incidence in 2020 compared with 2015, in India. A community-based survey, analysis of programme data and anti-TB drug sales and utilisation data. National TB Elimination Program and private TB treatment settings in 73 districts that had filed a claim to the Central TB Division of India for progress towards TB-free status. Each district was divided into survey units (SU) and one village/ward was randomly selected from each SU. All household members in the selected village were interviewed. Sputum from participants with a history of anti-TB therapy (ATT), those currently experiencing chest symptoms or on ATT were tested using Xpert/Rif/TrueNat. The survey continued until 30 We calculated a direct estimate of TB incidence based on incident cases identified in the survey. We calculated an under-reporting factor by matching these cases within the TB notification system. The TB notification adjusted for this factor was the estimate by the indirect method. We also calculated TB incidence from drug sale data in the private sector and drug utilisation data in the public sector. We compared the three estimates of TB incidence in 2020 with TB incidence in 2015. The estimated direct incidence ranged from 19 (Purba Medinipur, West Bengal) to 1457 (Jaintia Hills, Meghalaya) per 100 000 population. Indirect estimates of incidence ranged between 19 (Diu, Dadra and Nagar Haveli) and 788 (Dumka, Jharkhand) per 100 000 population. The incidence using drug sale data ranged from 19 per 100 000 population in Diu, Dadra and Nagar Haveli to 651 per 100 000 population in Centenary, Maharashtra. TB incidence in 1 state, 2 UTs and 35 districts had declined by at least 20% since 2015. Two districts in India were declared TB free in 2020.

Identifiants

pubmed: 35902192
pii: bmjopen-2021-060197
doi: 10.1136/bmjopen-2021-060197
pmc: PMC9340578
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e060197

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Investigateurs

Jayakrishna Kurada (J)
Mayank Sharma (M)
Shamim Mannan (S)
Debajyoti Mohapatra (D)
Yogesh Patel (Y)
Sapna Thekkepat (S)
Karthikeyan Kumaraswamy (K)
Mallika Tharakan (M)
Shramana Majumdar (S)
Vrinda Manocha (V)
Sukriti Chauhan (S)
Swati Mahajan (S)
Shekhar Waikar (S)
Puja Ambule (P)
Krithika Murali (K)
Devi Madhavi Bhimarasetty (DM)
Tulika Goswami (T)
Darshan Mahyavanshi (D)
Krutarth Bhrahmbhatt (K)
Bhautik Modi (B)
Anmol Gupta (A)
Sunil Raina (S)
Rajiv Kumar Gupta (RK)
Ratnesh Sinha (R)
Sairu Philip (S)
Aswathy Sreedevi (A)
Manju Toppo (M)
Lalit Sankhe (L)
Gajen Medhi (G)
Swati M Patki (SM)
Bishnu Ram Das (BR)
Lisa Sarangi (L)
Ganapathy Kalaiselvan (G)
Sarit Sharma (S)
Afsal Hakim (A)
Suresh Balan (S)
Baer Philip Ravikumar (BP)
Subrata Baidya (S)
Abhik Sinha (A)
Boddepalli Nagendra Naidu (BN)
Bikash Chandra Nayak (BC)
Anoop Dev (A)
Pallavi Boro (P)
Debarshi Paul (D)
Amrita Sarkar (A)
Bhavesh Bariya (B)
Paras Mehta (P)
Jatin Chhaya (J)
Dixit Chauhan (D)
Mithun Sanghavi (M)
Nilesh Thakor (N)
Rohit Ram (R)
Anupam Banerjee (A)
Hinal Baria (H)
Abhilash Sood (A)
Anupam Parashar (A)
Devender Kumar (D)
Yangchen Dolma (Y)
Rakesh Bahl (R)
Surinder Singh (S)
Dilip Kumar (D)
Mohammad Salim Khan (MS)
A K Jayasree (AK)
Zinia Nujum (Z)
Sheela P Haveri (SP)
Dinesh Bhatnagar (D)
Subrata Kumar Palo (SK)
Priyesh Marskole (P)
Prashant Verma (P)
Dinesh Kumar Pal (DK)
Neelam Toppo (N)
Sanjay R Quraishi (SR)
Sunil Panigrahi (S)
Rambadan Chauhan (R)
Jayashree Gothankar (J)
Swapnali S Kadam (SS)
Dasi Rao (D)
Vijay Singh (V)
Sudhir Wanje (S)
Pallavi Uplap (P)
Ningombam Joenna Devi (NJ)
Rikrak Ch Marak (RC)
Markordor Lyngdoh (M)
Manoj B Patki (MB)
Satyajit Sundar Ray (SS)
Kavita Vasudevan (K)
Mahesh Satija (M)
Jasleen Kaur (J)
Mahesh Choudhary (M)
Mitin Parmar (M)
Venkatesh Govindasamy (V)
Karlapudi Nitesh Kumar (KN)
Goutham Thumari (G)
Amar Tripura (A)
Chanda Mog (C)
Rituparna Das (R)
Shampa Das (S)
Ritesh Singh (R)
Chandra Shekar Maity (CS)
Mamta Gehlawat (M)

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Indian J Tuberc. 2021 Jan;68(1):51-58
pubmed: 33641851
PLoS One. 2012;7(7):e38691
pubmed: 22792158
Trop Med Int Health. 2021 Jul;26(7):730-742
pubmed: 33715264
Infect Dis Poverty. 2019 Oct 4;8(1):79
pubmed: 31581953
Indian J Tuberc. 2018 Oct;65(4):315-321
pubmed: 30522619
PLoS One. 2011;6(9):e24160
pubmed: 21912669
PLoS One. 2019 Feb 22;14(2):e0212264
pubmed: 30794595
JAC Antimicrob Resist. 2020 Oct 03;2(3):dlaa076
pubmed: 34223031
Indian J Tuberc. 2022 Apr;69(2):141-150
pubmed: 35379393
Lancet Infect Dis. 2016 Nov;16(11):1255-1260
pubmed: 27568356
Indian J Tuberc. 2020 Dec;67(4S):S139-S146
pubmed: 33308660
BMJ Glob Health. 2020 Nov;5(11):
pubmed: 33199280
Indian J Med Res. 2010 Oct;132:438-41
pubmed: 20966523
PLoS One. 2011 May 04;6(5):e18964
pubmed: 21573227
PLoS Med. 2016 Mar 02;13(3):e1001974
pubmed: 26934098

Auteurs

Kathiresan Jeyashree (K)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Jeromie Thangaraj (J)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Kiran Rade (K)

World Health Organization, Country Office for India, New Delhi, India.

Bhavesh Modi (B)

GMERS Medical College & Civil Hospital, Gandhinagar, Gujarat, India.

Sriram Selvaraju (S)

ICMR - National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.

Saravanakumar Velusamy (S)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Sasidharan Akhil (S)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Mathavaswami Vijayageetha (M)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Dhanapal Sudha Rani (D)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Ramasamy Sabarinathan (R)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Sakthivel Manikandanesan (S)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Rajalakshmi Elumalai (R)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Meenakumari Natarajan (M)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Bency Joseph (B)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Amarendra Mahapatra (A)

ICMR-Regional Medical Research Centre, Bhubaneswar, Orissa, India.

Almas Shamim (A)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Amar Shah (A)

USAID India Mission, New Delhi, Delhi, India.

Ashok Bhardwaj (A)

MM Medical College & Hospital, Kumarhatti, Solan, Himachal Pradesh, India.

Anil Purty (A)

Pondicherry Institute of Medical Sciences, Puducherry, India.

Bhavin Vadera (B)

Wadhwani Institute of Artificial Intelligence, Mumbai, India.

Anand Sridhar (A)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Aniket Chowdhury (A)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Asif Shafie (A)

Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.

Avijit Choudhury (A)

World Health Organization, Country Office for India, New Delhi, India.

Deka Dhrubjyoti (D)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Hardik Solanki (H)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Krushna Sirmanwar (K)

PATH India, New Delhi, India.

Kshitij Khaparde (K)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Malik Parmar (M)

World Health Organization, Country Office for India, New Delhi, India.

Nisha Dahiya (N)

Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.

Parija Debdutta (P)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Quazi Ahmed (Q)

CDC, New Delhi, Delhi, India.

Ranjani Ramachandran (R)

World Health Organization, Country Office for India, New Delhi, India.

Ranjeet Prasad (R)

Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.

Rohini Shinde (R)

Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.

Rupali Baruah (R)

Gauhati Medical College, Guwahati, Assam, India.

Sandeep Chauhan (S)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Sandip Bharaswadkar (S)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Shanta Achanta (S)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Burugina Nagaraja Sharath (BN)

ESIC Medical College and PGIMSR, Bengaluru-560010, Karnataka, India.

Shibu Balakrishnan (S)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Shivani Chandra (S)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Sophia Khumukcham (S)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Sudarsan Mandal (S)

Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.

Sumitha Chalil (S)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Vaibhav Shah (V)

WHO-NTEP Technical Assistance Project, New Delhi, India.

Venkatesh Roddawar (V)

PATH India, New Delhi, India.

Raghuram Rao (R)

Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.

Kuldeep Sachdeva (K)

Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.

Manoj Murhekar (M)

ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India mmurhekar@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH